Stock Trading Canary

Built: 2026-10-19T16:02:49+00:00 · 中文

← South Korea

SOUTH KOREA · OPENDART

Pharmicell Co.,Ltd.

파미셀 · 005690 · KOSPI · Healthcare · Biotechnology

Score

Not ranked: no net buying on the exchange by an individual insider in the last 180 days.

Insiders' buying price vs the latest close

Insiders paid 13,831.00 KRW a share on average (1 purchase line, 1 buyer, 2026-01-26 – 2026-01-26). The close on 2026-10-16 was 21.3% below that price.

Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.

Insider trades on the exchange

Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.

Trade dateInsiderRoleTradeSharesPriceValueFiling
2026-01-26Kim Hyun SooCEOBought on the exchange14,000₩13,831₩193.6MDART ↗
Other changes in holdings · 13

Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.

DateInsiderRoleReasonSharesFiling
2026-06-16Hyun Sul, SungDirectorOthers(+)668DART ↗
2026-06-16BAE EUI HANDirectorOthers(+)668DART ↗
2026-06-16LIM YOUNG JADirectorOthers(+)668DART ↗
2026-06-16JANG HAK SUNManaging directorOthers(+)668DART ↗
2026-06-16JEONG SOON WOONGManaging directorOthers(+)668DART ↗
2026-06-16KIM SU CHANVice presidentOthers(+)668DART ↗
2026-01-13Hyun Sul, SungDirectorNew appointment(+)978DART ↗
2025-03-06BAE EUI HANDirectorOthers(+)978DART ↗
2025-03-06JEONG SOON WOONGManaging directorOthers(+)2,371DART ↗
2025-03-06Jeong Gil SuSenior managing directorOthers(+)2,371DART ↗
2025-03-06JANG HAK SUNManaging directorOthers(+)2,371DART ↗
2025-03-06LIM YOUNG JADirectorOthers(+)635DART ↗
2025-03-06KIM SU CHANManaging directorOthers(+)2,371DART ↗